You are here

SARC018 - SPORE01

Active
SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Type of Sarcoma: 
Metastatic Leiomyosarcoma
Drug: 
Mocetinostat & Gemcitabine
Accrual Status: 
Ongoing,Not Accruing
Overall Study Principal Investigator: 
Shreyas Patel, MD
Co-Principal Investigator
MD Anderson Cancer Center

Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology
 

For more information about this trial and open sites: